Neurotrophic / BDNF and synaptic-plasticity claims · Peptide
Evidence gap: Route-specific human PK and absolute bioavailability are not established in the imported material.
Open in the interactive library →Compare with other compounds →
The guide describes experimental neurotrophic research.
Context: Imported field-guide summary; primary citation incomplete.
Limitations: No validated human dose; no primary study or route-specific PK supplied.
Administration reported for this specific study or labeled indication.
Context: Pregnant 3xTg-AD and wild-type mice
Animal study regimen: Amount: 60 nmol/g diet; Route: Oral, formulated chow; Frequency: Access to formulated chow; Duration: Embryonic day 8 to offspring postnatal day 21; Species: Mouse; Population: Pregnant 3xTg-AD and wild-type mice
Limitations: The amount is a concentration in maternal chow. The experiment measured Alzheimer-like behaviors and pathology in offspring.
Open this exact record in the library →Suggest a correctionThese compounds share an Atlas pathway label. That is a navigation connection, not evidence of equivalent effects or suitability together.
Browse this pathway in the library →Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.